Ischemic Heart Disease Flashcards

(74 cards)

0
Q

Unstable angina

A
  1. Rest
  2. New onset<2 mos
  3. Increasing angina by a class
    3 kinds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Types of angina

A
  1. Typical chest pain with exertion relieved at rest or ntg
  2. Atypical angina has only 2 of the 3
  3. Non cardiac chest pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anginal equivalents in diabetics, woman, and elderly

A

Dyspnea
Nausea
Fatigue
Faintness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of mi

A
Type 1 plaque rupture
Type 2 increase ischemic burden
Type3 death no enzymes
Type 4 sp pci 
Type 4b stent thrombosis
Type 5 sp MI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

> 75 years

A

MI usually NSTEMI not STEMI
More likely CHF
Increase mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mi therapy

A
No nitro if BP is low
No iv betablockers
Morphine OK
No  Norvasc 
Oxygen if o2 below 90
No IV acei
iV lopressor only if the pain is persistent
Oral acei if EF below 40
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Worst prognosis

A
St-t changes and the level of tropinin 
CHF 
PCI <6 mos
DM
RF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Volume of the contrast

A

3.7x creatinine clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Timacs study

A

High rusk patients benifit from early invasive therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prasugrel

A

Only in MI
Only after angio max
Donot pre load in the ER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dose

A

Use only 80 mg Asa with ticagrelor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Plavix dose

A

It could be given in the ER or at PCI both class1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cure study

A

Asa and plavix better than asprin alone
Use plavix for 1 year
Oasis7 high dose of plavix 600 and 150 is more effective the 300 and 75 but more bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Triton study

A

Increase risk of stroke and MI in cyp2c19 carriers than non carriers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Prasugrel

A

More effective, faster acting, and potent than pkavix.

Don’t use it before you cath and no abciximab in the ER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Triton 38

A
Don't use in stroke patients
Older
Less body weight
Decreased events in effient groups 
Decrease stent thrombosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ticagrelor

A
Reversible binds to p2y12
Short acting
Less stent thrombosis than pkavix
Can give ticagrelor even on pkavix
Side effects dyspnea asthma and heart block
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Renal failure

A

Adjust angio max dose

You can give angio max in the ER 2b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Acuity study

A

More bleeding with UFH and 2b 3a than with angio max
Fondoperimaux can cause increase thrombosis after PCI and according to the guide lines don’t need to be stopped till CABG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Triple anti thrombotic

A

Afib
CHF
Mechanical valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Post mi

A

Flu vaccine
Fish oil
Aldo blockage for low EF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Enzymes

A

Elevated tropinin for 10 days.

If myoglobin is negative no MI it has high negative predictive value

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Thrombolysis and tx in 3-24 hours to pci facility

A

Horizon study higher TLR with drug eluding vs BMS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Thrombolysis

A

Thrombolysis
75 yo use 75 mg pkavix
No data on effient or brillinta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
After Thrombolysis
PCI24 need 600 plavix All 2b 3a are class 2a indication sp mi
25
Sp tnk Thrombolysis
Enoxeparim less tan 75 bolus more than 75 no bolus
26
So mi
Eplerinone is class 1 for CHF Ephesus study
27
So mi
IABP no survival benifit | It's 2a indication
28
Sp | Mi
Ventricular rupture day 3-5 If they have Thrombolysis 24 hours MR post medial pap
29
Class of indication for 2b3a in mi
No class 1 all class2
30
Highest risk of mi
Black male 65-74
31
High risk in USA
``` Tropinin ST depression Age>75 Hypotension Ongoing chest pain pain at the time of the exam Crescendo angina past 48 hours ```
32
Duke score
Intermediate score risk 10% over 5 years
33
No treadmill for
``` LBBB and WPW STT depression >1mm Paced rhythm LVH Dig ```
34
Duke score | Exercise in min-5x max ST depression- 4x angina index 0 no cp 1 non limiting cp 2 limiting cp-
Low score more than +5 one year 1% 5 year 3% Intermediate risk score 4to -10 one year risk 1-3% five year 9.5% High risk greater than minus 11 one year 3% and give year 35%
35
High risk
Inability to achieve 85% HR Heart rate recovery less than 11 beats a min VEA VT
36
Sensitivity and specificity
Stress EKG sen 68% specific 77% Stress echo sen 80% specific 86% Nuclear sen 84% specific 77%
37
Adenosine
``` Binds to A2A causing increase cAMP and vaso dilatation Myocardial ischemia is rare A1 AV block A3A4 bronchospasm Hypotension 5% No caffeine Don't use HR slow or carotid stenosis ```
38
Persantine
Use caution in liver failure
39
Stress test recommendation
Intermediate risk interpretable EKG standard exercise EKG Intermediate risk un interpretable EKG do imaging
40
No stress tet
For low risk
41
CTA and MR
Low to intermediate risk No CTA if there are no symptoms Low risk less than 100 agaston units and less than 50% lesion Intermediate risk 100-399 one stenosis of 70% or two 50-69% High greater than 400 and multiple lesions
42
Swedish trial Normal LV and stable angina Decrease mortality and MI
Asprin only Not nitrates Not betablockers Definitely not ca blockers
43
Betablockers
Sp MI all patients with normal LV and continue for 3 years Decrease HR beta 1 Decrease after load beta 2 Decrease contractiliry beta 1 and 3 No data on metoprolol tartrate data only on metoprolol succinate
44
Acei Clear benifit in mi CHF and HTN Less clear in motmot endive normal LV
Hope Europa Camelot cv benifit | Pace, transcend and navigator no benifit
45
Medical therapy vs CABG 1972-79 VA study European study Cases
Only sub group benefited are 3 vessel Left main EF<50
46
Acme study
PCI has superior angina relief compared to medical therapy Small increase in emergency CABG Restenosis 40% PCI has no effect on mi or mortality
47
PTCA vs CABG | RITA ERACI CABRI EAST GABI BARI
Overall rates or mortality same CABG superior to pci in diabetics mortality Benifit of CABG in Diabetics due to Lima Fewer mi cases in CABG Less frequent angina in CABG
48
PTCA(balloon)vs bare metal stent
No deference in death mi or emergent CABG | Bare metal stents were helpful in angiographic restenosis and repeat pci
49
BMS vs CABG | Erica 2 ARTS SoS
Repeat revascularization low but still higher than CABG No mortality benifit between CABG and pci Did not achieve complete revascularization with pci
50
BMS vs medical therapy Courage 95% male VA study Class 4 angina medically stable Excluded ongoing chest pain, low EF,recent pci
``` Used asprin plavix Betablockers amlodipiine and nitrates Lisinopril Simvastatin Smoking cessation Weight loss ``` OMT and PCI are superior to OMT alone
51
Revascularization vs OMT in type 2DM | Bari 2D
Both are identical | Aggressive diabetic control showed no deference
52
Bari 2 D
PCI reduces angina PCI does not reduce mi or mortality Type 2 DM and SIHD revascularization vs medical therapy no change in mortality
53
CABG vs DES Syntax Low syntax scores high strokes with surgery
More repeat procedures with stent group Higher the syntax score( 22 )more cerebrovascukar complications with pci Higher MACCE with pci Overall adverse event rates are higher with pci 27% vs 37% Neither all cause mortality nor stroke are defferent in both groups Syntax greater than 33 much higher stroke and all cause mortality with pci But stroke
54
Freedom study DES and CABG Diabetes 2-3 vessels no left main
``` Higher death and stroke Higher mi with DES Higher stroke with CABG Higher repeat revascularization with pci Low syntax scores both are same ```
55
Stitch EF <35 No left main medical vs CABG
CABG did not reduce mortality but lower incidence of combined end points with CABG Myocardial viability was useless
56
Exercise no more than 30 min | 2 drinks a day
``` 1200-1500 cal for woman 1500-1800 for man 69% American are over weight Bmi over 30 All cause mortality 23% Dash <25% cal from fat ```
57
Jnc7
No alpha blockers as they worsen CHF
58
All HAT
Chlorthalidone amlodipine and lisinopril all same
59
Older patients over 60
Start treating at BP 150 | But be aggressive in DM blacks and RF
60
Metabolic x
``` Obesity >40 for men High tig Low LDL HTN Hyperglycemia 35% people inUS Doubles the risk ```
61
Lipid studies
TNT high and low Lipitor high is better
62
Woscoos
Low LDL | Decrease mi and CCA by 23%
63
Lipitor is better than pravastatin
High risk LDL <70 Intermediate risk 2 risk factors Start at 130 and get to 100 Low (0-1 risk factors) risk start at 190 and get to 160
64
Statin therapy
Do base line LFTs no need for yearly tests Zeros no survival data Niacin no survival data
65
Pre op high risk
``` Cad CHF Cva DM Rf Are all high risk No routine pre po beta blockers poise study has increase mortality ```
66
Pre op
Do not stop plavix for one year | HTN is not a risk factor in pre op
67
You can stop Coumadin in mechanical valves
Only of it is aortic and no other issues . | Resume in I week no bridging
68
After pci
Surgery 14 days after POBA 6 weeks after BMS 12 mos after DES
69
Intermediate risk for pre op
1-5% mi and death
70
Horizons study
Angio max | As effective as heparin and 2b 3a but safer less bleeding and less deaths
71
Lipid therapy
2 risk factors initial LDL therapy at 160
72
Stress test
Normsl test event rate less than 2% a year | High risk >20 per year
73
Greater than 50% patients
Will not have classic triad and atypical symptoms